Enhabit, Inc. (NYSE:EHAB) Shares Acquired by JPMorgan Chase & Co.

JPMorgan Chase & Co. grew its stake in Enhabit, Inc. (NYSE:EHAB - Free Report) by 37.8% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 305,245 shares of the company's stock after buying an additional 83,707 shares during the quarter. JPMorgan Chase & Co. owned 0.61% of Enhabit worth $2,411,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the stock. FMR LLC raised its holdings in Enhabit by 138.4% in the 3rd quarter. FMR LLC now owns 3,388 shares of the company's stock worth $27,000 after purchasing an additional 1,967 shares during the period. Quarry LP increased its stake in Enhabit by 242.2% during the 2nd quarter. Quarry LP now owns 3,703 shares of the company's stock worth $33,000 after buying an additional 2,621 shares in the last quarter. Gladius Capital Management LP increased its stake in Enhabit by 78.2% during the 3rd quarter. Gladius Capital Management LP now owns 6,259 shares of the company's stock worth $49,000 after buying an additional 2,747 shares in the last quarter. Franklin Resources Inc. increased its stake in Enhabit by 19.6% during the 3rd quarter. Franklin Resources Inc. now owns 32,382 shares of the company's stock worth $256,000 after buying an additional 5,317 shares in the last quarter. Finally, Public Sector Pension Investment Board increased its stake in Enhabit by 6.1% during the 2nd quarter. Public Sector Pension Investment Board now owns 110,385 shares of the company's stock worth $985,000 after buying an additional 6,351 shares in the last quarter.

Enhabit Stock Down 0.9 %

NYSE:EHAB traded down $0.07 during trading hours on Wednesday, hitting $7.92. The company's stock had a trading volume of 179,805 shares, compared to its average volume of 238,323. The stock has a market capitalization of $398.22 million, a P/E ratio of -3.41 and a beta of 1.82. The stock has a fifty day moving average of $7.83 and a 200-day moving average of $8.10. The company has a current ratio of 1.46, a quick ratio of 1.46 and a debt-to-equity ratio of 0.85. Enhabit, Inc. has a 52-week low of $6.85 and a 52-week high of $11.74.

Enhabit (NYSE:EHAB - Get Free Report) last posted its earnings results on Wednesday, November 6th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.04 by ($0.01). The business had revenue of $253.60 million during the quarter, compared to analysts' expectations of $261.69 million. Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. During the same period last year, the company earned $0.03 EPS. On average, equities analysts forecast that Enhabit, Inc. will post 0.22 earnings per share for the current year.

Insiders Place Their Bets

In related news, Director Stuart M. Mcguigan purchased 15,000 shares of the stock in a transaction that occurred on Tuesday, December 10th. The shares were purchased at an average price of $8.81 per share, with a total value of $132,150.00. Following the completion of the acquisition, the director now directly owns 46,810 shares in the company, valued at $412,396.10. This represents a 47.15 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Jeffrey Bolton purchased 4,000 shares of the stock in a transaction that occurred on Thursday, December 12th. The shares were bought at an average cost of $8.69 per share, for a total transaction of $34,760.00. Following the acquisition, the director now owns 98,144 shares of the company's stock, valued at approximately $852,871.36. The trade was a 4.25 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 1.90% of the company's stock.

Analysts Set New Price Targets

EHAB has been the subject of a number of analyst reports. Jefferies Financial Group upgraded Enhabit from a "hold" rating to a "buy" rating and upped their price target for the company from $8.25 to $9.50 in a research report on Monday, December 9th. Leerink Partners restated a "market perform" rating and issued a $8.00 price target (down from $8.50) on shares of Enhabit in a research report on Tuesday, November 19th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the company's stock. Based on data from MarketBeat.com, Enhabit has an average rating of "Hold" and a consensus price target of $8.75.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.